News from oramed pharmaceuticals inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Dec 03, 2014, 08:25 ET

Oramed Closes $5 Million Investment From Guangxi Wuzhou Pharmaceutical Company

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP), a developer of oral drug delivery systems, today announced that it has received $5 million in...

Dec 01, 2014, 08:15 ET

Oramed Pharmaceuticals at LD MICRO "Main Event" Micro-Cap Growth Conference on December 2, 2014

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...

Oct 31, 2014, 08:25 ET

Oramed to Report Key Top Line Results from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP)(http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...

Oct 24, 2014, 08:25 ET

Oramed to Present at the FireRock Annual Micro-Cap Conference

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...

Oct 22, 2014, 08:29 ET

Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com ), a clinical-stage pharmaceutical company focused on the development of oral...

Sep 15, 2014, 08:15 ET

Oramed to Present at Family Office & Wealth Management Conference

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...

Sep 03, 2014, 08:15 ET

Oramed to Present at Upcoming Conferences

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...

Aug 19, 2014, 08:15 ET

Oramed Granted Patent in Spain for Oral Administration of Insulin

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...

Aug 07, 2014, 08:20 ET

Oramed Pharmaceuticals Reports Last Patient Out in Phase IIa Trial for ORMD-0801 in Type 1 Diabetes

Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...

Jun 23, 2014, 08:15 ET

Oramed Pharmaceuticals to Present at the BIO International Convention in San Diego

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...

Jun 10, 2014, 08:15 ET

Oramed Pharmaceuticals to Present at the American Diabetes Association 74th Scientific Sessions on June 13 - 17, 2014 in San Francisco

  Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development...

May 29, 2014, 12:00 ET

Oramed Pharmaceuticals Added to the Morgan Stanley Capital International (MSCI) MicroCap Index

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...

May 27, 2014, 08:15 ET

Oramed to Present at Jefferies Global Healthcare Conference on June 2 in New York City

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug...

May 19, 2014, 07:00 ET

Oramed Pharmaceuticals to Present at the IATI Israel Innovation Conference in Tel Aviv

  Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP), a clinical-stage developer of oral delivery systems, announced today that Josh Hexter,...

May 13, 2014, 13:10 ET

Oramed to Present Poster on its Oral Insulin Capsule at the Yale Diabetes Symposium

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...

Apr 24, 2014, 14:30 ET

Oramed Pharmaceuticals Presents Data from Phase IIa Trial with ORMD-0801 in Type 2 Diabetes at the 2014 Diabetes Summit

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug...

Apr 10, 2014, 08:10 ET

Oramed Granted Patent in Hong Kong for Oral Administration of Insulin

 Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug...

Mar 27, 2014, 08:45 ET

Oramed Pharmaceuticals Announces First Patient Enrolled in a US Phase 2a Trial for ORMD-0801 in Treatment of Type 1 Diabetes

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...

Mar 11, 2014, 08:30 ET

Oramed Granted its 3rd Patent in Australia for Oral Administration of Exenatide

 Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of...

Mar 06, 2014, 08:20 ET

Oramed to Present at Upcoming Conferences

Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) (http://www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral...